Dr Bruno Di Muzio
on August 9, 2015
This case illustrates a common follow-up for glioblastoma in which an antiangiogenic chemotherapy (bevacizumab) was introduced after tumour recurr...”
View full size version of Glioblastoma NOS (bevacizumab pseudoresponse)
See the case: Glioblastoma NOS (bevacizumab pseudoresponse)
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.